Cargando…
Perioperative Minimal Induction Therapy: A Further Step toward More Effective Immunosuppression in Transplantation
Dual induction with low doses of rabbit anti-human thymoglobulin (RATG) and basiliximab effectively and safely prevented allograft rejection in high-risk renal transplant recipients. To assess whether treatment timing affects efficacy and tolerability, in this single-center, matched-cohort study, we...
Autores principales: | Gennarini, Alessia, Cravedi, Paolo, Marasà, Maddalena, Perna, Annalisa, Rota, Giovanni, Bontempelli, Mario, Sandrini, Silvio, Remuzzi, Giuseppe, Ruggenenti, Piero |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364007/ https://www.ncbi.nlm.nih.gov/pubmed/22685630 http://dx.doi.org/10.1155/2012/426042 |
Ejemplares similares
-
Mycophenolate mofetil versus azathioprine in kidney transplant recipients on steroid-free, low-dose cyclosporine immunosuppression (ATHENA): A pragmatic randomized trial
por: Ruggenenti, Piero, et al.
Publicado: (2021) -
Spironolactone Plus Full-Dose ACE Inhibition in Patients with Idiopathic Membranous Nephropathy and Nephrotic Syndrome: Does It Really Work?
por: Cravedi, Paolo, et al.
Publicado: (2010) -
Effect of Trandolapril on Regression of Retinopathy in Hypertensive Patients with Type 2 Diabetes: A Prespecified Analysis of the Benedict Trial
por: Ruggenenti, Piero, et al.
Publicado: (2010) -
Sexual dimorphic response to rituximab treatment: A longitudinal observational study in a large cohort of patients with primary membranous nephropathy and persistent nephrotic syndrome
por: Perna, Annalisa, et al.
Publicado: (2022) -
Full-dose NSAIDs at the first sign of respiratory infection? – Authors’ reply
por: Ruggenenti, Piero, et al.
Publicado: (2022)